Arkolith/Insider Trading/BCAX/Form 4

Raben David

Chief Medical OfficerBicara Therapeutics Inc. (BCAX) · full profile →Form 4 · filed Mar 5, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$306K
Net Open-Market Flow
-$306K
Transactions
6
4 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 4, 2026Option exercise(M)16K$3.79$62K72K
Mar 4, 2026Sell(S)16K$18.52$302K55K
Mar 3, 2026Sell(S)200$18.45$4K55K
Mar 3, 2026Option exercise(M)200$3.79$75855K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 4, 2026Option exercise(M)16K—$053K
Mar 3, 2026Option exercise(M)200—$069K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001628280-26-015419) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML